×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
A Critical Examination of the Strengths and Weaknesses of Different Project Management Models
Session Chair(s)
Richard J Heaslip, PhD
Founder
Programmatic Sciences LLC, United States
This forum will review the strengths and weaknesses of project management models commonly used for managing development projects in life science organizations. It will then explore how to define the best approach(es) for managing projects in any given organization.
Learning Objective : Describe the primary project management (and governance) models used by life science organizations to oversee their drug or device development projects; Compare the strengths and weaknesses of those models including the ideal circumstances for using each; Explain why the best model for managing a development project may change as projects become more complex, and as their sponsoring organizations grow.
Speaker(s)
Improving Project Management in Life Science Organizations: Which Project Management Model Is Ideal for You?
Richard J Heaslip, PhD
Programmatic Sciences LLC, United States
Founder
Project Management in Strategic Partnerships Between CROs and Sponsors
Robin G Foldesy, PhD
Quintiles Transnational Corp., United States
Vice President, Strategic Drug Development
Project Management in the Life Sciences Industry: Perspectives from Pharma, Devices and Diagnostics
Mark A. Lane, PhD, MS
Sanofi, United States
Assistant Vice President, PMO North American Medical Affairs
Have an account?
Ways to register
Registration override should work.